Intuniv Antitrust Settlement

By providing your information, either on paper, electronically or through a website, you consent to us storing and using your information for case administration purposes only. Our site uses tracking technologies to tailor your experience and understand how you and other visitors use our site. By continuing to navigate this site you consent to use of these tracking technologies. For more information on how we use your personal data, please read our Privacy Policy.

Intuniv Antitrust Settlement
Home
Home
Notice
Notice
Court Documents
Court Documents
Contact Us
Contact Us

The information contained on this webpage is only a summary.  You may download a copy of the full Notice by clicking here. 

Claim forms were mailed to all class members on February 12, 2021. To participate in the settlement, class members’ returned claim forms must be postmarked by March 15, 2021. Please contact us if you are a class member and have not received your claim form.  A copy of the blank claim form is available here.



If you bought brand or generic Intuniv directly from a manufacturer, you could get a payment from a proposed class action settlement.


There is a proposed settlement in a Class Action Lawsuit (the “Lawsuit”) pending in the United States District Court for the District of Massachusetts by Direct Purchasers of brand and generic Intuniv (extended-release guanfacine hydrochloride). The lawsuit asserts that Shire plc, Shire LLC, and Shire U.S., Inc. (“Shire”) and Actavis Elizabeth LLC, Actavis LLC, and Actavis Holdco US, Inc. (“Actavis”), the manufacturers of brand and generic Intuniv, violated antitrust laws in the sale of these products, causing Direct Purchasers to pay inflated prices for these products.


The settlement is on behalf of a Class of Direct Purchasers that purchased Intuniv and/or generic Intuniv in any form directly from Shire or Actavis, including any predecessor or successor of Shire or Actavis, from October 19, 2012, through June 1, 2015. The proposed settlement provides for payment of $19.9 million in cash for allocation to the members of the Class after payment of Class Counsel’s attorneys’ fees and costs out of the Settlement Fund, as approved by the Court. The Court has preliminarily approved the proposed settlement.

The proposed settlement is with Actavis only. It does not resolve any of the claims against Shire. The Direct Purchaser Lawsuit against Shire is proceeding.

For the full text of the proposed Settlement Agreement, along with other documents filed with the Court in this case, please visit the “Court Documents” section of this website.

For information to contact the Claim Administrator or Counsel to the Direct Purchaser Class, please visit the “Contact Us” section of this website.

 

YOUR LEGAL RIGHTS AND OPTIONS

WHEN YOU RECEIVE A CLAIM FORM, PROMPTLY COMPLETE AND RETURN IT

You do not need to do anything now to retain your right to seek a share of the proposed settlement. If the Court decides to give the proposed settlement Final Approval and you are a Class Member, then you will need to complete, sign and return a Claim Form (which will be mailed to you) to obtain a share of the proposed settlement.

OBJECT TO THE SETTLEMENT

If you object to all or any part of the proposed settlement, write to the Court about why you object to the proposed settlement.  The deadline to object to the proposed settlement is November 10, 2020.

 

Further information regarding the requirements for submitting an objection are included in the Notice.

ATTEND THE FAIRNESS HEARING

The Court will hold a Fairness Hearing at 10:00 a.m. on December 9, 2020, before Judge Allison D. Burroughs of the U.S. District Court for the District of Massachusetts, in Courtroom 17 of the United State Courthouse, 1 Courthouse Way, 5th Floor, Boston, MA 02210. 

 

If you plan to attend the hearing, please check this website for any changes in schedule or whether the hearing will be conducted in person or remotely.

 

 

adobe reader imageYou will need Adobe Reader to view documents on this site. You can learn more about Adobe Reader and download the latest version by clicking here.